cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Vbi Vaccines Inc
39 own
83 watching
Current Price
$0
$-0.04
(-1.44%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
23.93M
52-Week High
52-Week High
40.5
52-Week Low
52-Week Low
2.35
Average Volume
Average Volume
0M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization23.93M
icon52-Week High40.5
icon52-Week Low2.35
iconAverage Volume0M
iconDividend Yield--
iconP/E Ratio--
What does the Vbi Vaccines Inc do?
VBI Vaccines Inc., a commercial stage biopharmaceutical company, develops vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. It is developing eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccine technology, a vaccine formulation technology that enables the thermostabilization of vaccines through a proprietary formulation and freeze-drying process. The company also offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborn infants. In addition, it is developing CMV vaccine program, which is in Phase I clinical trials for the prevention of human cytomegalovirus infection; and for glioblastoma multiforme, which is in preclinical testing stage. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS.
Read More
News & Events about Vbi Vaccines Inc.
PR Newswire
2 months ago
Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results Brii Biosciences Provides Corporate Update and Reports Full-Year 2022 Financial Results PR Newswire DURHAM, N.C. and BEIJING, March 24, 2023 Company maintains priority focus on clinical programs to develop a...
Business Wire
3 months ago
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced interim data from the Phase 2 study evaluating the combination of VBI-2601 (BRII-179), VBIs HBV immunotherapeutic candidate, and...
Business Wire
6 months ago
The Coalition for Epidemic Preparedness Innovations (CEPI) is expanding its world-leading portfolio of potential variant-proof coronavirus vaccines in a deal with VBI Vaccines Inc. (Nasdaq: VBIV) to advance the development of multivalent coronavirus shots that could be deployed against COVID-19 as...
Business Wire
6 months ago
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that additional biomarker data from the Phase 1/2a study of VBI-1901, the Companys cancer vaccine immunotherapeutic candidate in...
Business Wire
7 months ago
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that its abstract highlighting data from the ongoing Phase 2a study of VBI-1901, the Companys cancer vaccine immunotherapeutic...
Frequently Asked Questions
Frequently Asked Questions
What is Vbi Vaccines Inc share price today?
plus_minus_icon
Can Indians buy Vbi Vaccines Inc shares?
plus_minus_icon
How can I buy Vbi Vaccines Inc shares from India?
plus_minus_icon
Can Fractional shares of Vbi Vaccines Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Vbi Vaccines Inc stocks?
plus_minus_icon
What is today’s traded volume of Vbi Vaccines Inc?
plus_minus_icon
What is today’s market capitalisation of Vbi Vaccines Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Vbi Vaccines Inc?
plus_minus_icon
What percentage is Vbi Vaccines Inc down from its 52-Week High?
plus_minus_icon
What percentage is Vbi Vaccines Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.04
(-1.44%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
RETRACTABLE TECHNOLOGIES INC
RETRACTABLE TECHNOLOGIES INC
$1.15
$0.00 (0.00 %)
Pieris Pharmaceuticals, Inc.
Pieris Pharmaceuticals, Inc.
$0.90
$-0.01 (-0.82 %)
ONCOCYTE CORP
ONCOCYTE CORP
$0.21
$0.00 (-0.30 %)
CEL-SCI Corp
CEL-SCI Corp
$2.53
$0.00 (0.00 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
RETRACTABLE TECHNOLOGIES INC
RETRACTABLE TECHNOLOGIES INC
$1.15
$0.00 (0.00 %)
Pieris Pharmaceuticals, Inc.
Pieris Pharmaceuticals, Inc.
$0.90
$-0.01 (-0.82 %)
ONCOCYTE CORP
ONCOCYTE CORP
$0.21
$0.00 (-0.30 %)
CEL-SCI Corp
CEL-SCI Corp
$2.53
$0.00 (0.00 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00